BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1340 related articles for article (PubMed ID: 17697572)

  • 1. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of intra-coronary injection of anisodamine on the slow-reflow phenomenon in patients with acute myocardial infarction after percutaneous coronary intervention].
    Wei YY; Fu XH; Liu J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Apr; 28(4):295-9. PubMed ID: 18543478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of intracoronary administration of anisodamine on no-reflow, ventricular function and systolic synchrony in acute myocardial infarction patients undergoing percutaneous coronary intervention].
    Fan WZ; Fu XH; Jiang YF; Gu XS; Wu WL; Li SQ; Liu J; Xue L; Wei YY; Hao GZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Oct; 35(10):908-13. PubMed ID: 18206037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention].
    Chen JL; Fu XH; Jiang YF; Fan WZ; Gu XS; Liu JJ; Geng W
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):197-9. PubMed ID: 18419949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary nitroprusside in the prevention of the no-reflow phenomenon in acute myocardial infarction.
    Pan W; Wang LF; Yu JH; Fan Y; Yang SS; Zhou LJ; Li Y; Li WM
    Chin Med J (Engl); 2009 Nov; 122(22):2718-23. PubMed ID: 19951602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
    J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
    Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
    Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W
    Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transradial application of PercuSurge GuardWire device during primary percutaneous intervention of infarct-related artery with high-burden thrombus formation.
    Yip HK; Chen MC; Chang HW; Kuo FY; Yang CH; Chen SM; Hung WC; Chen CJ; Cheng CI; Wu CJ
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):503-11. PubMed ID: 15065147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No-reflow phenomenon after acute myocardial infarction is associated with reduced clot permeability and susceptibility to lysis.
    Zalewski J; Undas A; Godlewski J; Stepien E; Zmudka K
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2258-65. PubMed ID: 17673704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction.
    Bax M; de Winter RJ; Schotborgh CE; Koch KT; Meuwissen M; Voskuil M; Adams R; Mulder KJ; Tijssen JG; Piek JJ
    J Am Coll Cardiol; 2004 Feb; 43(4):534-41. PubMed ID: 14975460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.
    Wang HJ; Lo PH; Lin JJ; Lee H; Hung JS
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):171-6. PubMed ID: 15390241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
    Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
    Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of infarct-related artery with myocardial bridging in patients with ST-elevation myocardial infarction and its impact upon percutaneous coronary intervention.
    Yan HB; Wang J; Zhu XL; Gao H; Li N; Ai H
    Chin Med J (Engl); 2006 Apr; 119(7):539-43. PubMed ID: 16620693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary streptokinase after primary percutaneous coronary intervention.
    Sezer M; Oflaz H; Gören T; Okçular I; Umman B; Nişanci Y; Bilge AK; Sanli Y; Meriç M; Umman S
    N Engl J Med; 2007 May; 356(18):1823-34. PubMed ID: 17476008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of admission glucose on epicardial and microvascular flow after primary angioplasty.
    Shen XH; Jia SQ; Li HW
    Chin Med J (Engl); 2006 Jan; 119(2):95-102. PubMed ID: 16454990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalisation of elevated ST segment predicts return of left ventricular systolic function and improved outcome in patients with acute myocardial infarction, treated with primary coronary angioplasty.
    Tomaszuk-Kazberuk A; Musiał WJ; Dobrzycki S; Korecki J
    Kardiol Pol; 2004 Jun; 60(6):541-9; discussion 550-1. PubMed ID: 15334154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.